-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Initiates Coverage On Opus Genetics with Buy Rating, Announces Price Target of $16

Benzinga·06/04/2026 15:29:18
Listen to the news
Guggenheim analyst Debjit Chattopadhyay initiates coverage on Opus Genetics (NASDAQ:IRD) with a Buy rating and announces Price Target of $16.